<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Heparin Neutralization | Hematology</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="Overview of Heparin Neutralization Assays Definition: Heparin neutralization assays are a group of laboratory tests used to determine if heparin is interfering with other coagulation assays or to...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="Heparin Neutralization | Hematology">
<meta property="og:type" content="book">
<meta property="og:description" content="Overview of Heparin Neutralization Assays Definition: Heparin neutralization assays are a group of laboratory tests used to determine if heparin is interfering with other coagulation assays or to...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Heparin Neutralization | Hematology">
<meta name="twitter:description" content="Overview of Heparin Neutralization Assays Definition: Heparin neutralization assays are a group of laboratory tests used to determine if heparin is interfering with other coagulation assays or to...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Hematology</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Erythrocytes</li>
<li><a class="" href="rbc-production.html">RBC Production</a></li>
<li><a class="" href="rbc-function.html">RBC Function</a></li>
<li><a class="" href="rbc-destruction.html">RBC Destruction</a></li>
<li><a class="" href="anemais.html">Anemais</a></li>
<li><a class="" href="microcytic.html">Microcytic</a></li>
<li><a class="" href="iron-deficiency.html">Iron Deficiency</a></li>
<li><a class="" href="chronic-disease.html">Chronic Disease</a></li>
<li><a class="" href="thalassemias.html">Thalassemias</a></li>
<li><a class="" href="sideroblastic.html">Sideroblastic</a></li>
<li><a class="" href="porphyria.html">Porphyria</a></li>
<li><a class="" href="normocytic.html">Normocytic</a></li>
<li><a class="" href="hereditary-hemolytic.html">Hereditary Hemolytic</a></li>
<li><a class="" href="acquired-hemolytic.html">Acquired Hemolytic</a></li>
<li><a class="" href="hypoproliferative.html">Hypoproliferative</a></li>
<li><a class="" href="acute-hemorrhage.html">Acute Hemorrhage</a></li>
<li><a class="" href="macrocytic.html">Macrocytic</a></li>
<li><a class="" href="megaloblastic.html">Megaloblastic</a></li>
<li><a class="" href="nonmegaloblastic.html">Nonmegaloblastic</a></li>
<li><a class="" href="hemoglobinopathies.html">Hemoglobinopathies</a></li>
<li><a class="" href="erythrocytosis.html">Erythrocytosis</a></li>
<li class="book-part">Leukocytes</li>
<li><a class="" href="wbc-production.html">WBC Production</a></li>
<li><a class="" href="wbc-function.html">WBC Function</a></li>
<li><a class="" href="wbc-destruction.html">WBC Destruction</a></li>
<li><a class="" href="benign-disorders.html">Benign Disorders</a></li>
<li><a class="" href="myeloid.html">Myeloid</a></li>
<li><a class="" href="lymphoid.html">Lymphoid</a></li>
<li><a class="" href="myeloid-neoplasia.html">Myeloid Neoplasia</a></li>
<li><a class="" href="aml.html">AML</a></li>
<li><a class="" href="myelodysplastic.html">Myelodysplastic</a></li>
<li><a class="" href="myeloproliferative.html">Myeloproliferative</a></li>
<li><a class="" href="lymphoid-neoplasia.html">Lymphoid Neoplasia</a></li>
<li><a class="" href="acute-lymphoid.html">Acute Lymphoid</a></li>
<li><a class="" href="chronic-b-cell.html">Chronic B-Cell</a></li>
<li><a class="" href="chronic-t-cell.html">Chronic T-Cell</a></li>
<li><a class="" href="plasma-cell.html">Plasma Cell</a></li>
<li class="book-part">Platelets</li>
<li><a class="" href="plt-production.html">PLT Production</a></li>
<li><a class="" href="plt-function.html">PLT Function</a></li>
<li><a class="" href="plt-destruction.html">PLT Destruction</a></li>
<li><a class="" href="quantitative.html">Quantitative</a></li>
<li><a class="" href="thrombocytopenia-1.html">Thrombocytopenia</a></li>
<li><a class="" href="destruction.html">Destruction</a></li>
<li><a class="" href="production.html">Production</a></li>
<li><a class="" href="pseudo.html">Pseudo</a></li>
<li><a class="" href="thrombocytosis.html">Thrombocytosis</a></li>
<li><a class="" href="qualitative.html">Qualitative</a></li>
<li><a class="" href="von-willebrand.html">von Willebrand</a></li>
<li><a class="" href="bernard-soulier.html">Bernard-Soulier</a></li>
<li><a class="" href="glanzmann.html">Glanzmann</a></li>
<li class="book-part">Laboratory</li>
<li><a class="" href="cell-counts.html">Cell Counts</a></li>
<li><a class="" href="manual.html">Manual</a></li>
<li><a class="" href="automated.html">Automated</a></li>
<li><a class="" href="retics.html">Retics</a></li>
<li><a class="" href="differentials.html">Differentials</a></li>
<li><a class="" href="morphologies.html">Morphologies</a></li>
<li><a class="" href="hemoglobin.html">Hemoglobin</a></li>
<li><a class="" href="quantitative-1.html">Quantitative</a></li>
<li><a class="" href="qualitative-1.html">Qualitative</a></li>
<li><a class="" href="electrophoresis.html">Electrophoresis</a></li>
<li><a class="" href="hplc.html">HPLC</a></li>
<li><a class="" href="sickle-solubility.html">Sickle Solubility</a></li>
<li><a class="" href="hematocrit.html">Hematocrit</a></li>
<li><a class="" href="indices.html">Indices</a></li>
<li><a class="" href="hemolysis.html">Hemolysis</a></li>
<li><a class="" href="special-stains.html">Special Stains</a></li>
<li><a class="" href="other-studies.html">Other Studies</a></li>
<li><a class="" href="esr.html">ESR</a></li>
<li><a class="" href="g6pd.html">G6PD</a></li>
<li><a class="" href="heinz-body.html">Heinz Body</a></li>
<li><a class="" href="flow-cytometry.html">Flow Cytometry</a></li>
<li><a class="" href="leukemia.html">Leukemia</a></li>
<li><a class="" href="lymphoma.html">Lymphoma</a></li>
<li><a class="" href="lymphocyte-subsets.html">Lymphocyte Subsets</a></li>
<li><a class="" href="pnh.html">PNH</a></li>
<li><a class="" href="molecularcytogenetic.html">Molecular/Cytogenetic</a></li>
<li><a class="" href="recurring-abnormalities.html">Recurring Abnormalities</a></li>
<li><a class="" href="bcrabl1.html">BCR/ABL1</a></li>
<li><a class="" href="jak2.html">JAK2</a></li>
<li class="book-part">Hemostasis</li>
<li><a class="" href="coagulation-pathways.html">Coagulation Pathways</a></li>
<li><a class="" href="fibrinolytic-pathways.html">Fibrinolytic Pathways</a></li>
<li><a class="" href="vascular-system.html">Vascular System</a></li>
<li><a class="" href="disorders.html">Disorders</a></li>
<li><a class="" href="factor-deficiencies.html">Factor Deficiencies</a></li>
<li><a class="" href="hereditary.html">Hereditary</a></li>
<li><a class="" href="acquired.html">Acquired</a></li>
<li><a class="" href="inhibitors.html">Inhibitors</a></li>
<li><a class="" href="fibrinolytic.html">Fibrinolytic</a></li>
<li><a class="" href="thrombophilia.html">Thrombophilia</a></li>
<li><a class="" href="dic.html">DIC</a></li>
<li><a class="" href="laboratory.html">Laboratory</a></li>
<li><a class="" href="ptinr.html">PT/INR</a></li>
<li><a class="" href="aptt.html">APTT</a></li>
<li><a class="" href="fibrinogen.html">Fibrinogen</a></li>
<li><a class="" href="d-dimer.html">D-dimer</a></li>
<li><a class="" href="thrombin-time.html">Thrombin Time</a></li>
<li><a class="" href="mixing-studies-1.html">Mixing Studies</a></li>
<li><a class="" href="factor-assays.html">Factor Assays</a></li>
<li><a class="" href="inhibitor-assays.html">Inhibitor Assays</a></li>
<li><a class="" href="von-willebrand-assays.html">von Willebrand Assays</a></li>
<li><a class="" href="platelet-function.html">Platelet Function</a></li>
<li><a class="" href="platelet-aggregation.html">Platelet Aggregation</a></li>
<li><a class="" href="thromboelastography.html">Thromboelastography</a></li>
<li><a class="" href="hypercoagulability.html">Hypercoagulability</a></li>
<li><a class="" href="assays.html">Assays</a></li>
<li><a class="" href="antiphospholipids.html">Antiphospholipids</a></li>
<li><a class="" href="protein-c.html">Protein C</a></li>
<li><a class="" href="protein-s.html">Protein S</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="fv-leiden.html">FV Leiden</a></li>
<li><a class="" href="pt-20210.html">PT 20210</a></li>
<li><a class="" href="anti-xa.html">Anti-Xa</a></li>
<li><a class="" href="thrombin-inhibitors.html">Thrombin Inhibitors</a></li>
<li><a class="active" href="heparin-neutralization.html">Heparin Neutralization</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Hematology/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="heparin-neutralization" class="section level1 unnumbered">
<h1>Heparin Neutralization<a class="anchor" aria-label="anchor" href="#heparin-neutralization"><i class="fas fa-link"></i></a>
</h1>
<div id="overview-of-heparin-neutralization-assays" class="section level2 unnumbered">
<h2>
<strong>Overview of Heparin Neutralization Assays</strong><a class="anchor" aria-label="anchor" href="#overview-of-heparin-neutralization-assays"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li><p><strong>Definition:</strong> Heparin neutralization assays are a group of laboratory tests used to determine if heparin is interfering with other coagulation assays or to assess the presence of heparin-induced antibodies</p></li>
<li>
<p><strong>Purpose:</strong></p>
<ul>
<li>Distinguishing between heparin contamination and true coagulation factor deficiencies in patients with prolonged clotting times (PT and/or aPTT)</li>
<li>Investigating unexpected or unexplained bleeding</li>
<li>Evaluating heparin responsiveness</li>
<li>Detecting heparin-dependent antibodies (e.g., in heparin-induced thrombocytopenia - HIT)</li>
</ul>
</li>
<li>
<p><strong>Two Main Categories:</strong></p>
<ul>
<li>Heparin Neutralization to Correct Clotting Assays: Used to determine if heparin is causing prolonged clotting times</li>
<li>Heparin Antibody Assays: Used to detect and identify antibodies against heparin-platelet factor 4 (PF4) complexes, as in Heparin Induced Thrombocytopenia (HIT)</li>
</ul>
</li>
</ul>
</div>
<div id="heparin-neutralization-to-correct-clotting-assays" class="section level2 unnumbered">
<h2>
<strong>Heparin Neutralization to Correct Clotting Assays</strong><a class="anchor" aria-label="anchor" href="#heparin-neutralization-to-correct-clotting-assays"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li><p><strong>Principle:</strong> These assays involve adding a heparin-neutralizing agent to the patient’s plasma to inactivate any heparin present, and then repeating the prolonged clotting test (PT and/or aPTT)</p></li>
<li><p><strong>Rationale:</strong> If the prolonged clotting time corrects after heparin neutralization, it suggests that the prolongation was due to heparin interference, rather than a true factor deficiency or inhibitor</p></li>
<li>
<p><strong>Methods:</strong></p>
<ul>
<li>Polybrene Neutralization:
<ul>
<li>Polybrene is a positively charged compound that binds to and neutralizes heparin (which is negatively charged)</li>
<li>Polybrene is added to the patient’s plasma before performing the clotting assay (PT or aPTT)</li>
</ul>
</li>
<li>Protamine Sulfate Neutralization:
<ul>
<li>Protamine sulfate is a positively charged protein that binds to and neutralizes heparin</li>
<li>Protamine sulfate is added to the patient’s plasma before performing the clotting assay (PT or aPTT)</li>
</ul>
</li>
<li>Heparinase Digestion:
<ul>
<li>Heparinase is an enzyme that degrades heparin</li>
<li>The patient’s plasma is incubated with heparinase to remove heparin, and then the clotting assay is performed</li>
</ul>
</li>
</ul>
</li>
<li>
<p><strong>Procedure:</strong></p>
<ol style="list-style-type: decimal">
<li>Prepare the Patient’s Plasma: Collect and prepare platelet-poor plasma (PPP) from the patient’s blood sample</li>
<li>Perform Baseline Clotting Assay (PT or aPTT): Measure the PT or aPTT on the untreated patient plasma</li>
<li>Prepare the Neutralized Plasma:
<ul>
<li>Add Polybrene, Protamine Sulfate, or Heparinase: Add the heparin-neutralizing agent to a portion of the patient’s plasma, following the manufacturer’s instructions</li>
<li>Incubate: Incubate the neutralized plasma for the recommended time (usually a few minutes)</li>
</ul>
</li>
<li>Perform the Clotting Assay on the Neutralized Plasma: Measure the PT or aPTT on the neutralized plasma</li>
<li>Compare Results: Compare the clotting time of the untreated plasma to the clotting time of the neutralized plasma</li>
</ol>
</li>
<li>
<p><strong>Interpretation:</strong></p>
<ul>
<li>Correction of Clotting Time: If the clotting time corrects (returns to the normal reference range) after heparin neutralization, it suggests that heparin was the cause of the prolonged clotting time</li>
<li>No Correction of Clotting Time: If the clotting time remains prolonged after heparin neutralization, it suggests that a factor deficiency or inhibitor is present, and heparin was not the sole cause of the prolonged clotting time</li>
</ul>
</li>
</ul>
</div>
<div id="heparin-antibody-assays-for-heparin-induced-thrombocytopenia---hit" class="section level2 unnumbered">
<h2>
<strong>Heparin Antibody Assays (for Heparin-Induced Thrombocytopenia - HIT)</strong><a class="anchor" aria-label="anchor" href="#heparin-antibody-assays-for-heparin-induced-thrombocytopenia---hit"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li><p><strong>Overview:</strong> These assays are used to detect antibodies against heparin-platelet factor 4 (PF4) complexes, which are characteristic of heparin-induced thrombocytopenia (HIT)</p></li>
<li>
<p><strong>HIT: A Quick Review:</strong></p>
<ul>
<li>HIT is a prothrombotic disorder caused by the formation of antibodies that bind to complexes of heparin and platelet factor 4 (PF4)</li>
<li>Antibody binding activates platelets, leading to thrombocytopenia (low platelet count) and an increased risk of thrombosis</li>
</ul>
</li>
<li>
<p><strong>HIT Diagnostic Algorithm</strong></p>
<ul>
<li>4Ts Score: Estimate clinical likelihood of HIT (Thrombocytopenia, Timing, Thrombosis, other causes for Thrombocytopenia)</li>
<li>If score indicates high or intermediate likelihood of HIT, perform the following tests</li>
</ul>
</li>
<li>
<p><strong>Assay Types</strong></p>
<ul>
<li>Enzyme-Linked Immunosorbent Assay (ELISA):
<ul>
<li>Principle: Detects antibodies against heparin-PF4 complexes</li>
<li>Procedure:
<ul>
<li>Microplate wells are coated with heparin-PF4 complexes</li>
<li>The patient’s serum or plasma is added to the wells, and any antibodies present bind to the heparin-PF4 complexes</li>
<li>An enzyme-labeled secondary antibody (e.g., anti-human IgG) is added, which binds to the bound antibodies</li>
<li>A substrate for the enzyme is added, and the resulting color change is measured spectrophotometrically</li>
</ul>
</li>
<li>Interpretation:
<ul>
<li>Optical Density (OD) values are measured, with a higher OD correlating to more antibodies present</li>
<li>Can differentiate between IgG, IgM, and IgA antibodies</li>
<li>A positive result indicates the presence of heparin-PF4 antibodies, but does not confirm platelet activation</li>
</ul>
</li>
</ul>
</li>
<li>Functional Assays:
<ul>
<li>Serotonin Release Assay (SRA) and Heparin-Induced Platelet Aggregation (HIPA)
<ul>
<li>Principle: Measures platelet activation in the presence of heparin and patient serum/plasma</li>
<li>Procedure:
<ul>
<li>Patient serum is incubated with normal donor platelets and heparin</li>
<li>Platelet activation is measured by:
<ul>
<li>Serotonin Release Assay (SRA): Measuring the release of serotonin from platelets</li>
<li>Heparin-Induced Platelet Aggregation (HIPA): Measuring platelet aggregation</li>
</ul>
</li>
</ul>
</li>
<li>Interpretation:
<ul>
<li>Positive: Indicates the presence of platelet-activating antibodies, confirming HIT</li>
</ul>
</li>
</ul>
</li>
<li>Advantages of Functional Assays:
<ul>
<li>Higher specificity than ELISA</li>
<li>Detect platelet-activating antibodies, which are more clinically relevant</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="factors-affecting-results" class="section level2 unnumbered">
<h2>
<strong>Factors Affecting Results</strong><a class="anchor" aria-label="anchor" href="#factors-affecting-results"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Pre-analytical:</strong>
<ul>
<li>Inappropriate sample type</li>
<li>Clotted samples</li>
<li>Improper handling or storage of the sample</li>
</ul>
</li>
<li>
<strong>Analytical:</strong>
<ul>
<li>Kit and reagent performance</li>
<li>Spectrophotometer functionality</li>
<li>Reader alignment and accuracy</li>
</ul>
</li>
<li>
<strong>Patient-related:</strong>
<ul>
<li>Recent heparin exposure</li>
<li>Concurrent medication and other factors</li>
</ul>
</li>
</ul>
</div>
<div id="troubleshooting-1" class="section level2 unnumbered">
<h2>
<strong>Troubleshooting</strong><a class="anchor" aria-label="anchor" href="#troubleshooting-1"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>If the results are unexpected, repeat the test and ensure that all steps were performed correctly</li>
</ul>
</div>
<div id="reflex-testing-12" class="section level2 unnumbered">
<h2>
<strong>Reflex Testing</strong><a class="anchor" aria-label="anchor" href="#reflex-testing-12"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>Positive HIT Antibody ELISA: This test can have high false-positive results so must be confirmed with SRA or HIPA assay</li>
</ul>
</div>
<div id="key-terms-107" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-107"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Heparin Neutralization:</strong> Inactivation of heparin’s anticoagulant activity</li>
<li>
<strong>Polybrene and Protamine Sulfate:</strong> Positively charged compounds that neutralize heparin</li>
<li>
<strong>Heparinase:</strong> An enzyme that degrades heparin</li>
<li>
<strong>Heparin-Induced Thrombocytopenia (HIT):</strong> A prothrombotic disorder caused by antibodies against heparin-PF4 complexes</li>
<li>
<strong>Functional Assay:</strong> Testing a samples ability to perform a certain task, which is used to confirm the presence of a functional antibody</li>
<li>
<strong>ELISA:</strong> Enzyme-Linked Immunosorbent Assay, which uses the binding properties of antibodies to confirm presence and quantity.</li>
<li>
<strong>PF4:</strong> Platelet Factor 4</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();
</script><div class="chapter-nav">
<div class="prev"><a href="thrombin-inhibitors.html">Thrombin Inhibitors</a></div>
<div class="empty"></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#heparin-neutralization">Heparin Neutralization</a></li>
<li><a class="nav-link" href="#overview-of-heparin-neutralization-assays">Overview of Heparin Neutralization Assays</a></li>
<li><a class="nav-link" href="#heparin-neutralization-to-correct-clotting-assays">Heparin Neutralization to Correct Clotting Assays</a></li>
<li><a class="nav-link" href="#heparin-antibody-assays-for-heparin-induced-thrombocytopenia---hit">Heparin Antibody Assays (for Heparin-Induced Thrombocytopenia - HIT)</a></li>
<li><a class="nav-link" href="#factors-affecting-results">Factors Affecting Results</a></li>
<li><a class="nav-link" href="#troubleshooting-1">Troubleshooting</a></li>
<li><a class="nav-link" href="#reflex-testing-12">Reflex Testing</a></li>
<li><a class="nav-link" href="#key-terms-107">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Hematology/blob/blob/main/book/05-35-hemostasis-laboratory-hypercoagulability-heparin-neutralization.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Hematology/blob/edit/main/book/05-35-hemostasis-laboratory-hypercoagulability-heparin-neutralization.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3" style="text-align: center; flex: 100%; max-width: 100%;">
    <p>Written by Brett M. Rice | Updated 2025-02-28 | Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div>

  <!--div class="col-12 col-md-6 mt-3">
    <p>Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div-->

</div></div>
</footer>
</body>
</html>
